94 related articles for article (PubMed ID: 28586473)
1. Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.
Marquet S; Bucheton B; Reymond C; Argiro L; El-Safi SH; Kheir MM; Desvignes JP; Béroud C; Mergani A; Hammad A; Dessein AJ
J Infect Dis; 2017 Jul; 216(1):22-28. PubMed ID: 28586473
[TBL] [Abstract][Full Text] [Related]
2. Biochemical Characterization of AGMO Variants Implicated in Relapses in Visceral Leishmaniasis.
Watschinger K; Keller MA; Golderer G; Coassin S; Zschocke J; Werner ER
J Infect Dis; 2018 May; 217(11):1846-1847. PubMed ID: 29741738
[No Abstract] [Full Text] [Related]
3. The alkylglycerol monooxygenase (AGMO) gene previously involved in autism also causes a novel syndromic form of primary microcephaly in a consanguineous Saudi family.
Alrayes N; Mohamoud HS; Ahmed S; Almramhi MM; Shuaib TM; Wang J; Al-Aama JY; Everett K; Nasir J; Jelani M
J Neurol Sci; 2016 Apr; 363():240-4. PubMed ID: 27000257
[TBL] [Abstract][Full Text] [Related]
4. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
[TBL] [Abstract][Full Text] [Related]
5. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM; Ismael A
Am J Trop Med Hyg; 1995 Apr; 52(4):299-305. PubMed ID: 7741164
[TBL] [Abstract][Full Text] [Related]
6. Alkylglycerol monooxygenase as a potential modulator for PAF synthesis in macrophages.
Tokuoka SM; Kita Y; Shindou H; Shimizu T
Biochem Biophys Res Commun; 2013 Jun; 436(2):306-12. PubMed ID: 23743196
[TBL] [Abstract][Full Text] [Related]
7. Genes and environment in susceptibility to visceral leishmaniasis.
El-Safi S; Kheir MM; Bucheton B; Argiro L; Abel L; Dereure J; Dedet JP; Dessein A
C R Biol; 2006 Nov; 329(11):863-70. PubMed ID: 17067929
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
[TBL] [Abstract][Full Text] [Related]
9. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
[TBL] [Abstract][Full Text] [Related]
10. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
[TBL] [Abstract][Full Text] [Related]
11. Congenital kala-azar and leishmaniasis in the placenta.
Eltoum IA; Zijlstra EE; Ali MS; Ghalib HW; Satti MM; Eltoum B; el-Hassan AM
Am J Trop Med Hyg; 1992 Jan; 46(1):57-62. PubMed ID: 1536385
[TBL] [Abstract][Full Text] [Related]
12. Leishmaniasis in Sudan. Visceral leishmaniasis.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
[TBL] [Abstract][Full Text] [Related]
13. Biallelic variants in AGMO with diminished enzyme activity are associated with a neurodevelopmental disorder.
Okur V; Watschinger K; Niyazov D; McCarrier J; Basel D; Hermann M; Werner ER; Chung WK
Hum Genet; 2019 Dec; 138(11-12):1259-1266. PubMed ID: 31555905
[TBL] [Abstract][Full Text] [Related]
14. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.
Bucheton B; Abel L; El-Safi S; Kheir MM; Pavek S; Lemainque A; Dessein AJ
Am J Hum Genet; 2003 Nov; 73(5):1052-60. PubMed ID: 14557985
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.
Tada H; Kawashiri MA; Nohara A; Saito R; Tanaka Y; Nomura A; Konno T; Sakata K; Fujino N; Takamura T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
Atherosclerosis; 2015 Jun; 240(2):324-9. PubMed ID: 25875382
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.
Mohamed HS; Ibrahim ME; Miller EN; Peacock CS; Khalil EA; Cordell HJ; Howson JM; El Hassan AM; Bereir RE; Blackwell JM
Genes Immun; 2003 Jul; 4(5):351-5. PubMed ID: 12847550
[TBL] [Abstract][Full Text] [Related]
17. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.
Collin S; Davidson R; Ritmeijer K; Keus K; Melaku Y; Kipngetich S; Davies C
Clin Infect Dis; 2004 Mar; 38(5):612-9. PubMed ID: 14986243
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
[TBL] [Abstract][Full Text] [Related]
19. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
[TBL] [Abstract][Full Text] [Related]
20. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
Meinecke CK; Schottelius J; Oskam L; Fleischer B
Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
